Position in TRLV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,179
New position
Shares Held
120
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#109
of 125 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HighMark Wealth Management LLC holds $55,297 across 10 Drug Manufacturers - Specialty & Generic names. TRLV ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORGO |
Organogenesis Holdings Inc.
|
11,829 | $28,744 | |
| 2 | CRON |
Cronos Group Inc.
|
3,000 | $8,340 | |
| 3 | VTRS |
Viatris Inc
|
509 | $8,082 | |
| 4 | TLRY |
Tilray Brands, Inc.
|
747 | $3,354 | |
| 5 | LQDA |
Liquidia Corp
|
25 | $1,993 | |
| 6 | HLN |
Haleon plc
|
207 | $1,931 | |
| 7 | TRLV |
Trulieve Cannabis Corp.
This page
|
120 | $1,179 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
55 | $1,109 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,179 | 120 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||